Dermatology/Skin - Other
12
1
1
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
8.3%
1 terminated out of 12 trials
88.9%
+2.4% vs benchmark
0%
0 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (12)
Application of the Belle.AI Dermatological Image Reference System for Patient Diagnosis in an Active Clinical Setting
Early Molecular Changes in Vitiligo After Narrowband Ultraviolet Therapy
Utility of Digital Dermoscopy in the Skin Cancer Clinic
Skin Tone Preferences and Their Influence on Skin Care Behaviors
Pilot Evaluation of Thulium Laser Alone or in Combination With Broad Band Light for Treatment of Dermatologic Conditions
Variable Perception of Cutaneous Stimulation
Project Options - The ABC Method
Animated Video Consultation for Reducing Pre-Operative Anxiety in Outpatient Dermatologic Surgery
Cutaneous and Mucosal Manifestations of Neurofribromatosis Type 2 in Children Under 15
An Exploratory Pilot Study in Healthy Volunteers to Assess the Parameters for the Design of Bioequivalence Studies on Moderately Lipophilic, Moderately to Highly Protein Bound Drugs Using Dermal Open Flow Microperfusion (dOFM)
Photograph Quality Rating Scale Study ("PQRS Study")
Desensitization of Nociceptive Afferents by Application of Topical Capsaicin, Trans-cinnamaldehyde and L-menthol